proteosome

(redirected from Proteasome)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for proteosome

a form of vaccine that can be administered by an inhaler

References in periodicals archive ?
B activation induced by LPS and was associated with decreased proteasome activity in rat primary macrophage culture.
OBJECTIVES: In these studies, we determined whether acute experimental exposure to two different aerosols altered white blood cell (WBC) or red blood cell (RBC) proteasome activity in human subjects.
The principle conclusion of the study was that plitidepsin, in combination with proteasome inhibitors, has the potential to provide a therapeutic alternative for multiple myeloma in light of the observed high antitumoral response and lack of impact on bone.
Marizomib is a novel, brain-penetrant proteasome inhibitor, which inhibits all three proteasome subunits.
Results: Proteasome activities following quercetin or rutin treatment were significantly augmented in comparison with non-treated cells.
Iceni Pharmaceuticals is planning a Phase II safety/efficacy trial of Cilcane starting in 2017 aimed at relapsed refractory patients who have already received one prior therapy of proteasome inhibitor.
Oleuropein activates the proteasome, the natural recycling system of skin cells to help reduce existing levels of AGE.
Clearance of oxidatively modified proteins most often occurs through the proteasome system.
They will work to identify compounds capable of inhibiting proteasome activity within the cells of malaria parasites, the action that is so critical to the parasite's survival.
The proteasome is a primary multi catalytic-protease-complex for selective degradation of more than 80% intracellular proteins.
Bortezomib is a reversible proteasome inhibitor, currently approved by US FDA for use in multiple myeloma and mantle cell lymphoma.
Topics to be discussed include deubiquitinating enzymes as drug targets, novel drug targets in the ubiquitin system, ubiquitin-like modifications, ubiquitin pathways in neurobiology, ubiquitin proteasome system and oncology, and proteasome structure and function.
Let's first take a look at one of the primary underlying causes of skin aging: loss of function of the proteasome.
The multi-center study with MLN9708, an investigational, oral proteasome inhibitor, will be conducted in Europe and North America.
Full browser ?